Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21116260 | 0.96 | AR (0.48) | ARPDK2TRPA1SCN9ASCN5A | |
| SCHEMBL21116261 | 0.93 | AR (0.45) | ARPDK2KIF11TRPA1SCN9A | |
| SCHEMBL23799193 | 0.91 | AR (0.38) | ARPDK2KIF11TRPA1SCN9A | |
| SCHEMBL23798211 | 0.90 | HSD11B1 (0.35) | ARPDK2KIF11TRPA1SCN9A | |
| SCHEMBL21116266 | 0.89 | AR (0.48) | ARPDK2TRPA1HSD11B1NR3C1 | |
| SCHEMBL21116341 | 0.89 | SCN9A (0.43) | ARTRPA1SCN9ASCN5AHSD11B1 | |
| SCHEMBL21131816 | 0.87 | AR (0.44) | ARPDK2KIF11TRPA1SCN9A | |
| SCHEMBL21116516 | 0.85 | KIF11 (0.38) | ARKIF11HSD11B1CYP11B1CYP11B2 | |
| SCHEMBL21116342 | 0.84 | SCN9A (0.46) | ARTRPA1SCN9ASCN5AHSD11B1 | |
| SCHEMBL21116557 | 0.84 | L3MBTL1 (0.40) | KIF11CYP11B2RORCALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| EP-3478656-B1 | DICARBAZOLE DIPHENYL DERIVATIVES FOR USE IN OPTOPELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-09-08 | — | — | EP | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | AR 1096/4885PDK2 3875/4885KIF11 3544/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | AR 1080/4885PDK2 3880/4885KIF11 3520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.